
|Videos|December 16, 2022
Selecting Between Treatment With Cabazitaxel or Radiotherapy for Patients with mCRPC
Author(s)Neal Shore, MD, FACS
Dr Shore details how he approaches treatment selection between cabazitaxel and radiotherapy for patients with mCRPC.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
CORE-008: Cretostimogene achieves high CR rate in high-risk NMIBC
2
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
3
Choosing salvage therapy after prostate cancer focal ablation
4
SYNC-T demonstrates high bone metastasis resolution in phase 1 cohort
5


















